Publicaciones en las que colabora con MARKEL LAFUENTE MERCHAN (12)

2024

  1. Hydrogel bioink formulation for 3D bioprinting: Sustained delivery of PDGF-BB and VEGF in biomimetic scaffolds for tendon partial rupture repair

    International Journal of Bioprinting, Vol. 10, Núm. 3, pp. 442-467

  2. Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives

    Biomedicine and Pharmacotherapy, Vol. 179

2023

  1. 3D Bioprinting for Ocular Applications

    3D Printing and Bioprinting for Pharmaceutical and Medical Applications (CRC Press), pp. 221-245

2022

  1. 3D Bioprinted Hydroxyapatite or Graphene Oxide Containing Nanocellulose-Based Scaffolds for Bone Regeneration

    Macromolecular Bioscience, Vol. 22, Núm. 11

  2. Chondroitin and Dermatan Sulfate Bioinks for 3D Bioprinting and Cartilage Regeneration

    Macromolecular Bioscience, Vol. 22, Núm. 3

  3. Progress in 3D Bioprinting Technology for Osteochondral Regeneration

    Pharmaceutics, Vol. 14, Núm. 8

2021

  1. Clay minerals as bioink ingredients for 3d printing and 3d bioprinting: Application in tissue engineering and regenerative medicine

    Pharmaceutics, Vol. 13, Núm. 11

  2. Current insights into 3D bioprinting: An advanced approach for eye tissue regeneration

    Pharmaceutics, Vol. 13, Núm. 3, pp. 1-28

  3. Development of scaffolds based on natural materials for tendon tissue regeneration

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 6-8

  4. Development, characterization and sterilisation of Nanocellulose-alginate-(hyaluronic acid)- bioinks and 3D bioprinted scaffolds for tissue engineering

    Materials Science and Engineering C, Vol. 126

  5. Hydroxyapatite and graphene oxide on nanocellulose-alginate ink for 3D bioprinting and bone regeneration

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 187-188

  6. Tendon tissue engineering: Cells, growth factors, scaffolds and production techniques

    Journal of Controlled Release, Vol. 333, pp. 448-486